Clinical Trials Directory

Trials / Sponsors / VectivBio AG

VectivBio AG

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
CompletedRelative Bioavailability of a New Presentation of Apraglutide Versus the Reference Formulation
Healthy Subjects
Phase 12023-05-23
CompletedEvaluation of Apraglutide on Gastric Emptying
Healthy Subjects
Phase 12023-03-02
CompletedA Phase 1 Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects
Hepatic Impairment
Phase 12023-01-30
TerminatedProof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD)
GVHD
Phase 22022-05-25
Active Not RecruitingOpen-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.
Short Bowel Syndrome
Phase 32021-07-13
CompletedMetabolic Balance Study of Apraglutide in Patients With Short Bowel Syndrome, Intestinal Failure (SBS-IF) and
Short Bowel Syndrome
Phase 22021-06-14
CompletedTrial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF
Short Bowel Syndrome
Phase 32021-01-26
CompletedStudy of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function.
Chronic Kidney Disease
Phase 12020-12-08